GENZYME CORP Fair Value, Measured on Recurring Basis, Investments (Deprecated 2011-01-31)
GENZYME CORP had Fair Value, Measured on Recurring Basis, Investments (Deprecated 2011-01-31) of $1.83 billion as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueMeasuredOnRecurringBasisInvestments · last filed 2011-03-01
- 2010-12-31: Fair Value, Measured on Recurring Basis, Investments (Deprecated 2011-01-31) $1.83B.
- 2010-09-30: Fair Value, Measured on Recurring Basis, Investments (Deprecated 2011-01-31) $1.08B.
- 2009-12-31: Fair Value, Measured on Recurring Basis, Investments (Deprecated 2011-01-31) $910.56M.
| Period end | Fair Value, Measured on Recurring Basis, Investments (Deprecated 2011-01-31) |
|---|---|
| 2010-12-31 | $1.83B 10-K · filed 2011-03-01 |
| 2010-09-30 | $1.08B 10-Q · filed 2010-11-09 |
| 2009-12-31 | $910.56M 10-K · filed 2011-03-01 |